C
Context Therapeutics Inc. (CNTX)
NCM – Real Time Price. Currency in USD
2.48
+0.09 (3.77%)
At close: May 12, 2026, 4:00 PM EDT
2.54
+0.06 (2.42%)
After-hours: May 12, 2026, 6:38 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.48
+0.09 (3.77%)
At close: May 12, 2026, 4:00 PM EDT
2.54
+0.06 (2.42%)
After-hours: May 12, 2026, 6:38 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.92 | 6.05 | 10 | |
| Quick ratio | 8.92 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -9K | -12K | -53K | -125K | -77K |
| Operating Income | -15M | -25M | -30M | -40M | -44M |
| Net Income | -15M | -24M | -27M | -36M | -40M |
| EBITDA | -15M | -25M | -30M | -40M | -43M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 7.78 | 3.5 |
| Next quarter | N/A | 13 | 4.5 |
| Current year | N/A | 2.05 | 2.0 |
| Next year | N/A | -5.37 | 1.0 |
| Weighted average score | 2.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 33.36 | 35.71 | -28.21 | 7.8 |
| Y/Y | 999 | -89.64 | -79.99 | -126.5 | 3.3 |
| 3y average | 999 | -36.05 | 8.48 | -33.32 | 4.5 |
| 5y average | 999 | -81.48 | 25.06 | -182.1 | 5.5 |
| Weighted average score | 5.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $54.5M significantly exceed its total debt $282.4K, ensuring strong financial flexibility
Total current assets $58.3M exceed Total current liabilities $6.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$11.5M limits the company's ability to reinvest or pay down debt